Pharmerica Corporation (PMC) Shares Bought by New York State Teachers Retirement System

New York State Teachers Retirement System lifted its position in shares of Pharmerica Corporation (NYSE:PMC) by 3.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 102,803 shares of the company’s stock after buying an additional 3,700 shares during the period. New York State Teachers Retirement System owned approximately 0.33% of Pharmerica Corporation worth $3,012,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company increased its holdings in shares of Pharmerica Corporation by 0.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 23,228 shares of the company’s stock worth $610,000 after buying an additional 71 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its holdings in Pharmerica Corporation by 0.9% in the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 11,614 shares of the company’s stock valued at $305,000 after purchasing an additional 100 shares in the last quarter. Capstone Asset Management Co. increased its holdings in Pharmerica Corporation by 0.9% in the 2nd quarter. Capstone Asset Management Co. now owns 16,041 shares of the company’s stock valued at $421,000 after purchasing an additional 150 shares in the last quarter. Louisiana State Employees Retirement System increased its holdings in Pharmerica Corporation by 1.6% in the 2nd quarter. Louisiana State Employees Retirement System now owns 12,700 shares of the company’s stock valued at $333,000 after purchasing an additional 200 shares in the last quarter. Finally, Arizona State Retirement System increased its holdings in Pharmerica Corporation by 1.2% in the 2nd quarter. Arizona State Retirement System now owns 16,216 shares of the company’s stock valued at $426,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 86.01% of the company’s stock.

Shares of Pharmerica Corporation (NYSE PMC) opened at C$29.10 on Friday. Pharmerica Corporation has a twelve month low of C$22.00 and a twelve month high of C$29.50. The stock has a market capitalization of $905.59, a price-to-earnings ratio of 15.08, a P/E/G ratio of 1.27 and a beta of 0.82. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.57 and a quick ratio of 1.79.

Pharmerica Corporation (NYSE:PMC) last announced its earnings results on Thursday, November 9th. The company reported C$0.46 earnings per share for the quarter, missing the consensus estimate of C$0.49 by C($0.03). The business had revenue of C$595.10 million for the quarter, compared to analyst estimates of C$596.80 million. Pharmerica Corporation had a net margin of 0.83% and a return on equity of 10.99%. equities analysts anticipate that Pharmerica Corporation will post 1.92 earnings per share for the current year.

WARNING: “Pharmerica Corporation (PMC) Shares Bought by New York State Teachers Retirement System” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/12/pharmerica-corporation-pmc-shares-bought-by-new-york-state-teachers-retirement-system.html.

PMC has been the subject of several recent research reports. Zacks Investment Research downgraded Pharmerica Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. BidaskClub downgraded Pharmerica Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 31st. KeyCorp downgraded Pharmerica Corporation to an “overweight” rating in a report on Wednesday, August 2nd. Barrington Research downgraded Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a report on Thursday, August 3rd. Finally, UBS AG reiterated a “neutral” rating and issued a $29.25 price target (up from $26.00) on shares of Pharmerica Corporation in a report on Thursday, August 3rd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. Pharmerica Corporation has a consensus rating of “Hold” and an average price target of C$30.50.

About Pharmerica Corporation

Institutional Ownership by Quarter for Pharmerica Corporation (NYSE:PMC)

Receive News & Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply